Article

Cardiorespiratory events detected by home memory monitoring and one-year neurodevelopmental outcome.

National Center on Sleep Disorders Research, National Heart, Lung, and Blood Institute, 6705 Rockledge Dr, Ste 6022, Bethesda, MD 20892-7993, USA.
Journal of Pediatrics (Impact Factor: 3.74). 11/2004; 145(4):465-71. DOI: 10.1016/j.jpeds.2004.05.045
Source: PubMed

ABSTRACT To determine if infants with cardiorespiratory events detected by home memory monitoring during early infancy have decreased neurodevelopmental performance.
Infants (n = 256) enrolled in the Collaborative Home Infant Monitoring Evaluation also completed the Bayley Scales of Infant Development II at 92 weeks' postconceptional age. Infants were classified as having 0, 1 to 4, or 5+ cardiorespiratory events. Events were defined as apnea >or=20 seconds or heart rate <60 to 80 bpm or <50 to 60 bpm, for >or=5 to 15 seconds, depending on age.
For term infants, having 0, 1 to 4, and 5+ cardiorespiratory events was associated with unadjusted mean Mental Developmental Index (MDI) values (+/-SD) of 103.6 (10.6), 104.2 (10.7), and 97.7 (10.9), respectively, and mean Psychomotor Developmental Index (PDI) values of 109.5 (16.6), 105.8 (16.5), and 100.2 (17.4). For preterm infants, having 0, 1 to 4, and 5+ cardiorespiratory events was associated with unadjusted mean MDI values of 100.4 (10.3), 96.8 (11.5), and 95.8 (10.6), respectively, and mean PDI values of 91.7 (19.2), 93.8 (15.5), and 94.4 (17.7). The adjusted difference in mean MDI scores with 5+ events compared with 0 events was 5.6 points lower in term infants ( P = .03) and 4.9 points lower in preterm infants ( P = .04).
Having 5+ conventional events is associated with lower adjusted mean differences in MDI in term and preterm infants.

Full-text

Available from: Rangasamy Ramanathan, Jun 11, 2015
0 Followers
 · 
179 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The infant car seat challenge (ICSC), or period of observation in a car safety seat before discharge to monitor for episodes of apnea, bradycardia and desaturation, is one of the most common tests performed on preterm neonates in the United States. However, the utility of the ICSC to identify infants at risk for adverse cardiopulmonary events in the car seat remains unclear. Minimal evidence exists to guide clinicians in performance of this test including appropriate inclusion criteria and failure criteria. In this article, the origins of the ICSC are discussed as well as potential etiologies of desaturations and bradycardia in the car seat position. Current literature on implementation, inclusion and failure criteria, incidence of failure and data on the meaning of a 'passed' vs 'failed' ICSC are discussed. Emphasis is made on minimizing time in car seats and seated devices given concern over the risk of desaturations.Journal of Perinatology advance online publication, 12 February 2015; doi:10.1038/jp.2015.1.
    Journal of perinatology: official journal of the California Perinatal Association 02/2015; 35(4). DOI:10.1038/jp.2015.1 · 2.35 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: IMPORTANCE Preterm infants have immature respiratory control and resulting intermittent hypoxia (IH). The extent of IH after stopping routine caffeine treatment and the potential for reducing IH with extended caffeine treatment are unknown. OBJECTIVES To determine (1) the frequency of IH in premature infants after discontinuation of routine caffeine treatment and (2) whether extending caffeine treatment to 40 weeks' postmenstrual age (PMA) reduces IH. DESIGN, SETTING, AND PARTICIPANTS A prospective randomized clinical study was conducted at 16 neonatal intensive care units in the United States, with an 18-month enrollment period. Preterm infants (<32 weeks' gestation) previously treated with caffeine were randomized to extended caffeine treatment or usual care (controls) at a PMA of at least 34 weeks but less than 37 weeks. Continuous pulse oximeter recordings were obtained through 40 weeks' PMA. Oximeter data were analyzed by persons masked to patient group. INTERVENTION Continued treatment with caffeine. MAIN OUTCOMES AND MEASURES Number of IH events and seconds with less than 90% hemoglobin oxygen saturation (Sao2) per hour of recording. RESULTS Our analysis included 95 preterm infants. In control infants, the mean (SD) time at less than 90% Sao2 at 35 and 36 weeks' PMA was 106.3 (89.0) and 100.1 (114.6) s/h, respectively. The number of IH events decreased significantly from 35 to 39 weeks' PMA (P = .01). Extended caffeine treatment reduced the mean time at less than 90% Sao2 by 47% (95% CI, -65% to -20%) to 50.9 (48.1) s/h at 35 weeks and by 45% (95% CI, -74% to -17%) to 49.5 (52.1) s/h at 36 weeks. CONCLUSIONS AND RELEVANCE Substantial IH persists after discontinuation of routine caffeine treatment and progressively decreases with increasing PMA. Extended caffeine treatment decreases IH in premature infants. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT01875159.
    01/2014; 168(3). DOI:10.1001/jamapediatrics.2013.4371
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Schlafbezogene Atmungsstörungen (SBAS) gehören zu den häufigsten Erkrankungen im Kindesalter. Dennoch sind ihre Symptome und differenzialdiagnostischen Schritte nicht allen Kinderärzten bekannt, sodass viele Kinder mit SBAS nicht adäquat versorgt werden. Diese Übersicht soll auf die unterschiedlichen Formen, die typische Symptomatik und die diagnostischen und therapeutischen Möglichkeiten bei SBAS aufmerksam machen. Ziel ist es, diese Erkrankungen bekannter zu machen, um damit die Versorgung von Kindern mit diesen Störungen zu verbessern. Sleep-disordered breathing (SDB) is one of the most important disorders of sleep and breathing in childhood. Knowledge of the symptoms and diagnostic work-up is comparatively sparse among pediatricians. Hence, numerous children with this disorder are not managed adequately. The aim of this review is to increase knowledge on the different types of SDB in children, its public health impact, diagnostic procedures and the therapeutic options for its management.
    Monatsschrift Kinderheilkunde 07/2007; 155(7):608-615. DOI:10.1007/s00112-007-1556-z · 0.28 Impact Factor